Deep learning integrates histopathology and proteogenomics at a pan-cancer level

Proteogenomics Interpretability Predictive power
DOI: 10.1016/j.xcrm.2023.101173 Publication Date: 2023-08-14T14:26:55Z
AUTHORS (124)
ABSTRACT
We introduce a pioneering approach that integrates pathology imaging with transcriptomics and proteomics to identify predictive histology features associated critical clinical outcomes in cancer. utilize 2,755 H&E-stained histopathological slides from 657 patients across 6 cancer types CPTAC. Our models effectively recapitulate distinctions readily made by human pathologists: tumor vs. normal (AUROC = 0.995) tissue-of-origin 0.979). further investigate power on tasks not normally performed H&E alone, including TP53 prediction pathologic stage. Importantly, we describe morphologies previously utilized setting. The incorporation of identifies pathway-level signatures cellular processes driving features. Model generalizability interpretability is confirmed using TCGA. propose classification system for these tasks, suggest potential applications this integrated machine learning approach. A publicly available web-based platform implements models.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (9)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....